Properties
Description
YLF-466D downregulates metabolic and energy homeostasis pathways, affecting cellular energy balance and potentially influencing cancer and metabolic disorders. It targets AMPK.
Molecular Formula
C29H20ClNO3
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
YLF-466D is utilized to examine its role as an inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) in cancer research.